These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4160054)

  • 41. [Clinical study of a new ovulation inhibitor].
    Lecart C
    Schweiz Rundsch Med Prax; 1970 Jun; 59(25):933-6. PubMed ID: 5513424
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
    Loskant G; Heinen G
    Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
    Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
    Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
    [No Abstract]   [Full Text] [Related]  

  • 44. [Endometrial reaction to chlormadinone acetate in monophasic and biphasic cycle regulation. I. Long-term treatment with small doses].
    Bayer R
    Z Geburtshilfe Gynakol; 1965 Jun; 164(1):47-61. PubMed ID: 4158135
    [No Abstract]   [Full Text] [Related]  

  • 45. [Serum enzyme examinations in the climacteric under the treatment with the estrogen-gestagen combination Ovosiston].
    Müller W; Bonow A; Klinger G; Hempel E
    Zentralbl Gynakol; 1969 Jul; 91(27):867-73. PubMed ID: 4188685
    [No Abstract]   [Full Text] [Related]  

  • 46. [Sequential treatment. Experimental and clinical study].
    Di Paola G; Mendizábal A; Usubiaga I; Ortega F
    Rev Argent Endocrinol Metab; 1966 Sep; 12(3):158-72. PubMed ID: 4170552
    [No Abstract]   [Full Text] [Related]  

  • 47. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston].
    Methfessel HD; Mlytz H; Methfessel G; Löffler F
    Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation].
    Krzywdziński K; Jedrzejewski M; Teter J
    Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038
    [No Abstract]   [Full Text] [Related]  

  • 49. [Intrahepatic cholestasis following ovosiston].
    Kraatz G; Linke A
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experience in the management of ovulation disorders in the mare].
    Baier W; Berchtold M; Brummer H
    Wien Tierarztl Monatsschr; 1972 Jan; 59(1):13-5. PubMed ID: 4109898
    [No Abstract]   [Full Text] [Related]  

  • 51. [New possibilities in the conservative treatment of nasopharyngeal angiofibroma].
    Mülfay M; Draşoveanu C; Mülfay G; Florea C; Rodean A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1982; 27(4):247-53. PubMed ID: 6192468
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pure hyperfolliculinism treated with a synthetic progestational agent].
    Ribon M; Petry JM; Brunel G; Landes P; Schweitzer M
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(3):332-3. PubMed ID: 4097900
    [No Abstract]   [Full Text] [Related]  

  • 53. [Our clinical experience with ethynodiol diacetate, alone or combined in variable doses with mestranol].
    Colin R
    Gynecol Obstet (Paris); 1966; 65(4):537-43. PubMed ID: 5971381
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical study of a progestational hormone in low doses].
    Gaudefroy M
    Bull Fed Soc Gynecol Obstet Lang Fr; 1965; 17(5):442-3. PubMed ID: 5866398
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical study of a synthetic progestagen at low doses].
    Gaudefroy M
    Gynecol Prat; 1966; 17():337-43. PubMed ID: 5987259
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical study of a synthetic progestative agent in small doses: Ovariostat Organon].
    Gaudefroy M
    J Sci Med Lille; 1966 Mar; 84(3):127-36. PubMed ID: 5931056
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacological inhibition of ovulation].
    Haller J
    Fortschr Geburtshilfe Gynakol (1950); 1965; 21():37-106. PubMed ID: 12255694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [10 years of research using steroids as controllers of ovulation].
    Martínez-Manautou J
    Gac Med Mex; 1968 Dec; 98(12):1560-75. PubMed ID: 4182066
    [No Abstract]   [Full Text] [Related]  

  • 59. Responsiveness of the pituitary to stimulation with arginine, GRH and TRH in patients with Turner's syndrome (karyotype 45, XO).
    Kunkel S; Rudolf K; Kyank H; Woltanski P; Pelz L
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():84-9. PubMed ID: 6085921
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of constitutional hereditary gigantism in girls].
    Lindner J; Dempe A; Bauch K
    Z Arztl Fortbild (Jena); 1981 Mar; 75(6):267-9. PubMed ID: 6169207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.